Ibogaine molecule:

Image from PubChem

Ibogaine Clinical Trials


Noribogaine Therapy for Relief of Opioid withdrawal, Phase 1B


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12613001064796

Organisation Name: DemeRx Inc

Overal Status: Completed

Start Date: 01/10/2013

Brief Summary: This is a research study to evaluate the safety, tolerability and effects of noribogaine, an atypical opioid. We will also be looking at its effects on opioid withdrawal symptoms in opioid dependent people who are maintained on stable doses of methadone and who want to stop taking methadone.

Countries:
  • New Zealand
  • United States of America


Total execution time in seconds: 0.084429979324341